Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Samsung Biologics | Seoul | Healthcare | Pharmaceuticals | ₩73.52T | 56.5x | 1.34 | ₩1,033,000 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.8% Upside | Upgrade to Pro+ | |
Alteogen | KOSDAQ | Healthcare | Pharmaceuticals | ₩23.35T | 167.3x | 0.5 | ₩437,000 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.3% Upside | Upgrade to Pro+ | |
Yuhan | Seoul | Healthcare | Pharmaceuticals | ₩8.56T | 124.6x | -2.71 | ₩104,700 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Yuhan | Seoul | Healthcare | Pharmaceuticals | ₩8.56T | 124.6x | -2.71 | ₩114,400 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.1% Upside | Upgrade to Pro+ | |
Sk Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩7.88T | 29x | 0.02 | ₩100,600 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.1% Upside | Upgrade to Pro+ | |
Pharma Reaserch Products | KOSDAQ | Healthcare | Pharmaceuticals | ₩7.11T | 42.9x | 1.46 | ₩684,000 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17% Upside | Upgrade to Pro+ | |
Sam Chun Dang Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩4.31T | -340.4x | 20.94 | ₩185,200 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SK Bioscience Co | Seoul | Healthcare | Pharmaceuticals | ₩3.66T | -69x | 0.24 | ₩46,650 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -18.5% Downside | Upgrade to Pro+ | |
Hanmi Pharm Co | Seoul | Healthcare | Pharmaceuticals | ₩3.54T | 35.2x | -1.05 | ₩279,500 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.6% Upside | Upgrade to Pro+ | |
Hugel | KOSDAQ | Healthcare | Pharmaceuticals | ₩3.22T | 28.7x | 0.43 | ₩317,000 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 45.1% Upside | Upgrade to Pro+ | |
Hanmi Science | Seoul | Healthcare | Pharmaceuticals | ₩2.83T | 55.5x | -0.96 | ₩41,850 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Caregen | KOSDAQ | Healthcare | Pharmaceuticals | ₩2.4T | 50x | -6.68 | ₩49,050 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -22.5% Downside | Upgrade to Pro+ | |
Celltrion Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩2.35T | 84x | ₩54,000 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
ST Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.87T | 62.3x | 2.35 | ₩92,800 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.3% Upside | Upgrade to Pro+ | |
GC Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩1.54T | 51.4x | 0.27 | ₩134,600 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.6% Upside | Upgrade to Pro+ | |
Daewoong Pharma | Seoul | Healthcare | Pharmaceuticals | ₩1.54T | 48.3x | -0.6 | ₩134,000 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hanall Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩1.48T | -763.8x | 6.35 | ₩29,250 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47% Upside | Upgrade to Pro+ | |
Nature Cell | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.36T | -9,589.7x | -76.5 | ₩21,050 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oscotec | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.32T | 2,739.3x | 33.75 | ₩34,500 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HK Inno.N | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.27T | 30.1x | ₩45,000 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Mezzion Pharma | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.13T | -52.1x | 0.42 | ₩37,400 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chong Kun Dang Pharma | Seoul | Healthcare | Pharmaceuticals | ₩1.09T | 11.7x | -0.23 | ₩83,000 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.5% Upside | Upgrade to Pro+ | |
Daewoong | Seoul | Healthcare | Pharmaceuticals | ₩918B | 16.6x | -0.27 | ₩22,450 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.7% Upside | Upgrade to Pro+ | |
Medy-Tox | KOSDAQ | Healthcare | Pharmaceuticals | ₩851.45B | 64x | 0.05 | ₩121,300 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dongkook Pharmaceutical | KOSDAQ | Healthcare | Pharmaceuticals | ₩786.63B | 13.9x | 0.97 | ₩17,720 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.8% Upside | Upgrade to Pro+ | |
Shinpoong Pharmaceutical Co | Seoul | Healthcare | Pharmaceuticals | ₩727.88B | -52.3x | -0.72 | ₩26,550 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shinpoong Phar | Seoul | Healthcare | Pharmaceuticals | ₩727.88B | -52.3x | -0.72 | ₩13,700 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Boryung Pharm | Seoul | Healthcare | Pharmaceuticals | ₩717.88B | 13.1x | -0.78 | ₩8,550 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Donga Socio Holdings | Seoul | Healthcare | Pharmaceuticals | ₩709.86B | 10.6x | 0.48 | ₩110,300 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.5% Upside | Upgrade to Pro+ | |
Green Cross Holdings | Seoul | Healthcare | Pharmaceuticals | ₩709.7B | 11.6x | 0.05 | ₩29,050 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Green Cross | Seoul | Healthcare | Pharmaceuticals | ₩709.7B | 11.6x | 0.05 | ₩15,560 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharmicell | Seoul | Healthcare | Pharmaceuticals | ₩700.25B | -18.8x | ₩11,670 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Il Dong Pharma | Seoul | Healthcare | Pharmaceuticals | ₩650.09B | -129.3x | -2.49 | ₩21,050 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Humedix | KOSDAQ | Healthcare | Pharmaceuticals | ₩610.95B | 56.7x | ₩59,200 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Huons Global | KOSDAQ | Healthcare | Pharmaceuticals | ₩603.52B | 22.8x | -0.6 | ₩49,550 | 3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
JW Pharmaceutical | Seoul | Healthcare | Pharmaceuticals | ₩512.62B | 9.3x | 0.2 | ₩62,300 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
JW Pharmaceutical | Seoul | Healthcare | Pharmaceuticals | ₩512.62B | 9.3x | 0.2 | ₩29,450 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jw Pharmac | Seoul | Healthcare | Pharmaceuticals | ₩512.62B | 9.3x | 0.2 | ₩22,300 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Binex | KOSDAQ | Healthcare | Pharmaceuticals | ₩512.11B | -20.3x | 0.3 | ₩16,560 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HLB Life Science | KOSDAQ | Healthcare | Pharmaceuticals | ₩491.65B | -3.3x | 0.01 | ₩4,035 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eubiologics | KOSDAQ | Healthcare | Pharmaceuticals | ₩465.49B | ₩12,710 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18% Upside | Upgrade to Pro+ | |||
Dong-A St | Seoul | Healthcare | Pharmaceuticals | ₩421.97B | -545.8x | -6.18 | ₩46,050 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.7% Upside | Upgrade to Pro+ | |
Qurient | KOSDAQ | Healthcare | Pharmaceuticals | ₩414.48B | -15.7x | -0.76 | ₩10,910 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioPlus | KOSDAQ | Healthcare | Pharmaceuticals | ₩411.51B | 22x | -1.96 | ₩6,990 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Komipharm Intl | KOSDAQ | Healthcare | Pharmaceuticals | ₩399.2B | 29x | 0.05 | ₩5,620 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Inventage Lab | KOSDAQ | Healthcare | Pharmaceuticals | ₩395.38B | ₩36,850 | 5.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Yungjin Pharm | Seoul | Healthcare | Pharmaceuticals | ₩380.42B | 41.7x | ₩2,080 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Kolon Life Science | KOSDAQ | Healthcare | Pharmaceuticals | ₩377.67B | -4.8x | 0.03 | ₩30,400 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellbion | KOSDAQ | Healthcare | Pharmaceuticals | ₩360.14B | -35.7x | ₩28,100 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Vivozon Healthcare | KOSDAQ | Healthcare | Pharmaceuticals | ₩354.77B | -23.6x | 0.06 | ₩7,160 | -4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |